Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress

International Journal of Neuropsychopharmacology

Volumn 15, Issue 2, 2012, Pages 235-246

  Fumagalli, Fabio ^a,b   Calabrese, Francesca ^a   Luoni, Alessia ^a   Bolis, Francesca ^a   Racagni, Giorgio ^a,b,c   Riva, Marco A ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Center of Excellence on Neurodegenerative Diseases   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Antipsychotic drugs; Arc; corticosterone; neurotrophin; schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LURASIDONE; MESSENGER RNA;

ACUTE STRESS DISORDER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; FORCED SWIMMING TEST; HIPPOCAMPUS; LONG TERM CARE; MALE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ACUTE DISEASE; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENE EXPRESSION REGULATION; ISOINDOLES; MALE; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; THIAZOLES;

EID: 84857366642     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000150     Document Type: Article

References (46)

1. Aid T, Kazantseva A, Piirsoo M, Palm K, et al. (2007). Mouse and rat BDNF gene structure and expression revisited. Journal of Neuroscience Research 85, 525-535.
2. Bramham CR, Worley PF, Moore MJ, Guzowski JF (2008). The immediate early gene arc/arg3.1: regulation, mechanisms, and function. Journal of Neuroscience 28, 11760-11767.
3. Brown AS (2011). The environment and susceptibility to schizophrenia. Progress in Neurobiology 93, 23-58.
4. Calabrese F, Molteni R, Cattaneo A, Macchi F, et al. (2010). Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. Molecular Pharmacology 77, 846-853.
5. Calabrese F, Molteni R, Racagni G, Riva MA (2009). Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34 (Suppl. 1), S208-S216.
6. Chiaruttini C, Sonego M, Baj G, Simonato M, et al. (2008). BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae. Molecular and Cellular Neuroscience 37, 11-19. (Pubitemid 350299994)
7. Duman RS (2009). Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues in Clinical Neurosciences 11, 239-255.
8. Dynes JL, Steward O (2007). Dynamics of bidirectional transport of Arc mRNA in neuronal dendrites. Journal of Comparative Neurology 500, 433-447.
9. Enomoto T, Floresco SB (2009). Effects of the novel antipsychotic lurasidone on prefrontal cognitive functioning in rats. Program No. 646.24/V36. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2009 [http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=8b18cef2-4639-46f5- af04-7625 da5790ff&cKey=76a08cde-72f9-4217-b21b-f1659636cf3d& mKey={081F7976-E4CD-4F3D-A0AF-E8387992A658}].
10. Enomoto T, Ishibashi T, Tokuda K, Ishiyama T, et al. (2008). Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats. Behavioral Brain Research 186, 197-207. (Pubitemid 350122756)
11. Fuchikami M, Morinobu S, Kurata A, Yamamoto S, et al. (2009). Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. International Journal of Neuropsychopharmacology 12, 73-82.
12. Fumagalli F, Bedogni F, Perez J, Racagni G, et al. (2004). Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. European Journal of Neuroscience 20, 1348-1354. (Pubitemid 39233585)
13. Fumagalli F, Cattaneo A, Caffino L, Ibba M, et al. (2010). Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacological Research 62, 523-529.
14. Fumagalli F, Pasini M, Frasca A, Drago F, et al. (2009). Prenatal stress alters glutamatergic system responsiveness in adult rat prefrontal cortex. Journal of Neurochemistry 109, 1733-1744.
15. Fumagalli F, Racagni G, Colombo E, Riva MA (2003). BDNF gene expression is reduced in the frontal cortex of dopamine transporter knockout mice. Molecular Psychiatry 8, 898-899.
16. Glantz LA, Lewis DA (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry 57, 65-73. (Pubitemid 30035660)
17. Green MJ, Matheson SL, Shepherd A, Weickert CS, et al. (2010). Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiatry. Published online: 24 August 2010. doi :10.1038/mp.2010.88.
18. Greenberg ME, Xu B, Lu B, Hempstead BL (2009). New insights in the biology of BDNF synthesis and release: implications in CNS function. Journal of Neuroscience 29, 12764-12767.
19. Guscott M, Bristow LJ, Hadingham K, Rosahl TW, et al. (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48, 492-502. (Pubitemid 40332407)
20. Ishibashi T, Horisawa T, Tokuda K, Ishiyama T, et al. (2010). Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. Journal of Pharmacology and Experimental Therapeutics 334, 171-181.
21. Ishiyama T, Tokuda K, Ishibashi T, Ito A, et al. (2007). Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. European Journal of Pharmacology 572, 160-170. (Pubitemid 47429645)
22. Koenig JI (2006). Schizophrenia: a unique translational opportunity in behavioral neuroendocrinology. Hormones and Behaviour 50, 602-611. (Pubitemid 44314174)
23. Kolluri N, Sun Z, Sampson AR, Lewis DA (2005). Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. American Journal of Psychiatry 162, 1200-1202. (Pubitemid 40770705)
24. Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression. Nature 455, 894-902.
25. Lewis D, Hashimoto T, Volk D (2005). Cortical inhibitory neurons and schizophrenia. Nature Reviews Neuroscience 6, 312-324. (Pubitemid 40469985)
26. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, et al. (2008). Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacological Reviews 60, 358-403.
27. Lubin FD, Roth TL, Sweatt JD (2008). Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. Journal of Neuroscience 28, 10576-10586.
28. Martinowich K, Manji H, Lu B (2007). New insights into BDNF function in depression and anxiety. Nature Neuroscience 10, 1089-1093. (Pubitemid 47339961)
29. McClung CA, Nestler EJ (2008). Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33, 3-17. (Pubitemid 350191310)
30. Meyer JM, Loebel AD, Schweizer E (2009). Lurasidone: a new drug in development for schizophrenia. Expert Opinion on Investigational Drugs 18, 1715-1726.
31. Minichiello L (2009). TrkB signalling pathways in LTP and learning. Nature Reviews Neuroscience 10, 850-860.
32. Molteni R, Calabrese F, Cattaneo A, Mancini M, et al. (2009a). Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 34, 1523-1532.
33. Molteni R, Calabrese F, Racagni G, Fumagalli F, et al. (2009b). Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacology and Therapeutics 124, 74-85.
34. Nakamura M, Ogasa M, Guarino J, Phillips D, et al. (2009). Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial. Journal of Clinical Psychiatry 70, 829-836.
35. Pattabiraman PP, Tropea D, Chiaruttini C, Tongiorgi E, et al. (2005). Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo. Molecular and Cellular Neuroscience 28, 556-570. (Pubitemid 40311858)
36. Paxinos G, Watson C (1996). The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
37. Roceri M, Cirulli F, Pessina C, Peretto P, et al. (2004). Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biological Psychiatry 55, 708-714. (Pubitemid 38376182)
38. Roceri M, Hendriks W, Racagni G, Ellenbroek BA, et al. (2002). Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Molecular Psychiatry 7, 609-616.
39. Sakata K, Woo NH, Martinowich K, Greene JS, et al. (2009). Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proceedings of the National Academy of Sciences USA 106, 5942-5947.
40. Terry AV, Buccafusco JJ, Wilson C (2008). Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets. Behavioral Brain Research 195, 30-38.
41. van Os J, Rutten BP, Poulton R (2008). Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia Bulletin 34, 1066-1082.
42. Wang JW, Dranovsky A, Hen R (2008). The when and where of BDNF and the antidepressant response. Biological Psychiatry 63, 640-641. (Pubitemid 351329282)
43. Weickert CS, Hyde TM, Lipska BK, Herman MM, et al. (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Molecular Psychiatry 8, 592-610. (Pubitemid 36898018)
44. Wibrand K, Messaoudi E, Havik B, Steenslid V, et al. (2006). Identification of genes co-upregulated with Arc during BDNF-induced long-term potentiation in adult rat dentate gyrus in vivo. European Journal of Neuroscience 23, 1501-1511.
45. Yasuda S, Liang MH, Marinova Z, Yahyavi A, et al. (2009). The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Molecular Psychiatry 14, 51-59.
46. Ying SW, Futter M, Rosenblum K, Webber MJ, et al. (2002). Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. Journal of Neuroscience 22, 1532-1540. (Pubitemid 35386272)